Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
VERTICAL Phase II trial results for NHL released

VERTICAL Phase II trial results for NHL released

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

VELCADE based regimens are cost-effective for payers and patients, finds study

VELCADE based regimens are cost-effective for payers and patients, finds study

Endo Pharmaceuticals receives FDA complete response letter for AVEED NDA

Endo Pharmaceuticals receives FDA complete response letter for AVEED NDA

XenaCare Holdings becomes national sponsor of Arthritis Foundation

XenaCare Holdings becomes national sponsor of Arthritis Foundation

Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles

Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles

FDA approves Qutenza, a pain relief product for patients who suffer from PHN

FDA approves Qutenza, a pain relief product for patients who suffer from PHN

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

Positive results from Winston Laboratories' Civamide Patch trial

Positive results from Winston Laboratories' Civamide Patch trial

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Endo Pharmaceuticals reaches patent litigation settlement with LecTec

Endo Pharmaceuticals reaches patent litigation settlement with LecTec

EpiCept announces third quarter 2009 financial results

EpiCept announces third quarter 2009 financial results

Third-quarter 2009 financial results announced by Inhibitex

Third-quarter 2009 financial results announced by Inhibitex

American Shared Hospital Services reports financial results for the third quarter of 2009

American Shared Hospital Services reports financial results for the third quarter of 2009

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Update from Endo Pharmaceuticals regarding its New Drug Application for FORTESTA

Update from Endo Pharmaceuticals regarding its New Drug Application for FORTESTA

Cobroxin OTC pain reliever is now available online

Cobroxin OTC pain reliever is now available online

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

GSK reports positive Phase II results from trial evaluating GSK1838262 for post-herpetic neuralgia

GSK reports positive Phase II results from trial evaluating GSK1838262 for post-herpetic neuralgia